Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation

Experimental Hematology

Volumn 30, Issue 7, 2002, Pages 697-702

  Nosaka, Tetsuya ^b   Kitamura, Toshio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; INTERLEUKIN 3; PROTEIN; PROTEIN KINASE PIM 1; PROTEIN TYROSINE KINASE; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HEMATOPOIETIC CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TEMPERATURE;

ANIMALS; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; FUSION PROTEINS, BCR-ABL; GENE DOSAGE; GENES, DOMINANT; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-3; MICE; MILK PROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEOPLASM PROTEINS; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-PIM-1; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TEMPERATURE; TRANS-ACTIVATORS;

MURINAE;

EID: 0036320651     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00808-1     Document Type: Article

References (48)

1. bcr-abl transformation of murine myeloid cells
2. bcr/abl: Implication for RAS-dependent Philadelphia chromosome positive cell growth
3. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the BCR/ABL oncogene
4. BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binging protein Rac
5. Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1
6. C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis
7. Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants
8. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
9. Transformation of hematopoietic cells by BCR/ABL requires the activation of a PI-3k/Akt-dependent pathway
10. Tyrosine phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by BCR/ABL
11. BCR/ABL leads to the constitutive activation of STAT proteins, and shares an epitope with tyrosine phosphorylated STAT5
12. bcr/abl induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
13. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia
14. A requirement for NF-κB activation in Bcr-Abl-mediated transformation
15. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
16. Dominant negative MYC blocks transformation by ABL oncogenes
17. Tumorigenic activity of the BCR/ABL oncogenes is mediated by BCL-2
18. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase
19. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells
20. + leukemia
21. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia
22. dok: A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells
23. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok
24. BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis
25. Reversibility of acute B-cell leukaemia induced by BCR-ABL1
26. STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells
27. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
28. L
29. r 33000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells
30. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
31. The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases
32. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias
33. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow
34. Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells
35. Analysis of Pim-1 function in mutant mice
36. PIM1 reconstitutes thymus cellularity in interleukin 7- and common γ chain-mutant mice and permits thymocyte maturation in Rag- but not CD3γ-deficient mice
37. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice
38. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors
39. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
40. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias
41. Plat-E: An efficient and stable system for transient packaging of retroviruses
42. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG
43. Characterization of the proto-oncogene pim-1: Kinase activity and substrate recognition sequence
44. Pim-1 kinase and p100 cooperate to enhance c-Myb activity
45. BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members
46. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients
47. Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides
48. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of Stat5